EpistemisPralidoxime (2-PAM)
Common trade names: Protopam, Contrathion.
Mechanism
Pharmacological Group and Molecular Target
Enzymatic reactivator of the high affinity nucleophilic oxime family.
Detailed Mechanism of Action
Organophosphate insecticides inactivate the enzyme acetylcholinesterase (AChE) by phosphorylating its serine residue in the catalytic active site. This covalent bond is extremely strong and undergoes over time a chemical deakilation process known as "aging" of the enzyme, which is irreversible once completed.
Pralidoxime has a positively charged quaternary ammonium nitrogen that binds by electrostatic attraction to the free anionic site of the phosphorylated cholinesterase. The nucleophilic oxime group of pralidoxime is optimally oriented to attack the phosphorus atom of the organophosphate insecticide, cleaving the phosphoric-serine ester bond, forming an inactive oxime-organophosphate conjugate and restoring the free catalytic activity of the functional AChE enzyme.
Critical Time Limit to Avoid Enzymatic "Aging"
The process of enzymatic reactivation by oximes is clinically useless once the enzyme has undergone biochemical aging. The aging time varies drastically depending on the molecular structure of the organophosphate compound involved:
Soman (Nerve Gas): Ages in 2 to 6 minutes (Oximes ineffective if not administered instantly) Dimethoate (Insecticide): Ages in 12 to 24 hours (Moderate therapeutic window) Chlorpyrifos or Methylparathion: Ages in 30 to 48 hours (Expanded therapeutic window)Pharmacokinetics
Pharmacokinetic and Toxicokinetic Profile
- Distribution: It does not bind significantly to plasma proteins. Being a hydrophilic quaternary ammonium compound, it does not easily cross the blood-brain barrier under normal conditions, therefore it lacks a direct effect on central nervous system (CNS) cholinergic toxicity compared to its potent effect on peripheral nicotinic receptors at the neuromuscular junction.
- Metabolism: Minimal hepatic.
- Excretion: Renal; 80% is excreted unchanged in the urine in the first 6 hours by active tubular secretion and glomerular filtration.
- Elimination half-life: Short, between 1 and 1.5 hours.
Indicators and dose
Specific Clinical Indications
- Treatment of toxicity by organophosphate pesticides and cholinesterase-related inhibitors, in obligatory combination with atropine.
- Treatment of profound neuromuscular weakness and paralysis of respiratory muscles (Intermediate Syndrome) associated with organophosphates.
Dosage Scheme and Infusion Protocols
- Loading Dose (Adults): 1 g to 2 g administered IV diluted in 100 mL of 0.9% physiological saline to infuse over a period of 15 to 30 minutes. An excessively rapid infusion can cause neuromuscular rigidity, reflex tachycardia, and severe hypertension.
- Maintenance Dose: Continuous intravenous infusion of 500 mg/hour to avoid a sudden drop in effective therapeutic concentrations (maintenance of plasma levels greater than 4 mg/L).
- Renal adjustment: In proven renal failure (eGFR <30 mL/min), the continuous infusion rate should be reduced by half (50%) to avoid plasma accumulation.
Security
Contraindications and Precautions
- Absolute Contraindication: Pure poisoning by carbamate insecticides (such as Carbaril), given that enzymatic carbamylation is transient and self-limiting, and the use of pralidoxime can increase the affinity of the toxin for the synaptic receptor, worsening neuromuscular symptoms (with the exception of combined or aldicarb poisoning).
Epistemis is educational review material. It is not a medical device, does not diagnose or prescribe treatment, and does not replace formal medical training, current clinical guidelines, or professional clinical judgment.
- System
- Antidotes and Toxicology
- Cluster
- Acetylcholinesterase Reactivator